Spago Nanomedical AB (publ) (STO:SPAGO)

Spago Nanomedical AB Revenue

Spago Nanomedical AB had revenue of 1.07M SEK in the quarter ending March 31, 2026, a decrease of -29.05%. This brings the company's revenue in the last twelve months to 4.38M, down -34.90% year-over-year. In the year 2025, Spago Nanomedical AB had annual revenue of 4.47M, down -32.85%.

• Revenue (ttm): 4.38M
• Revenue Growth: -34.90%
• P/S Ratio: 21.31
• Revenue / Employee: 876.80K
• Employees: 5
• Market Cap: 93.41M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.47M	-2.19M	-32.85%
Dec 31, 2024	6.66M	1.01M	17.95%
Dec 31, 2023	5.64M	-562.00K	-9.06%
Dec 31, 2022	6.20M	-279.00K	-4.30%
Dec 31, 2021	6.48M	-679.00K	-9.48%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 4, 2026

Data Sources Report a data error